Abstract:Hippo pathway transcriptional coactivators TAZ and YAP and the TGF-β1 (TGFβ) effector Smad3 regulate a common set of genes, can physically interact, and exhibit multilevel cross-talk regulating cell fate-determining and fibrogenic pathways. However, a key aspect of this cross-talk, TGFβ-mediated regulation of TAZ or YAP expression, remains uncharacterized. Here, we show that TGFβ induces robust TAZ but not YAP protein expression in both mesenchymal and epithelial cells. TAZ levels, and to a lesser extent YAP levels, also increased during experimental kidney fibrosis. Pharmacological or genetic inhibition of Smad3 did not prevent the TGFβ-induced TAZ up-regulation, indicating that this canonical pathway is dispensable. In contrast, inhibition of p38 MAPK, its downstream effector MK2 (e.g. by the clinically approved antifibrotic pirferidone), or Akt suppressed the TGFβ-induced TAZ expression. Moreover, TGFβ elevated TAZ mRNA in a p38-dependent manner. Myocardin-related transcription factor (MRTF) was a central mediator of this effect, as MRTF silencing/inhibition abolished the TGFβ-induced TAZ expression. MRTF overexpression drove the TAZ promoter in a CC(A/T-rich)6GG (CArG) box-dependent manner and induced TAZ protein expression. TGFβ did not act by promoting nuclear MRTF translocation; instead, it triggered p38- and MK2-mediated, Nox4-promoted MRTF phosphorylation and activation. Functionally, higher TAZ levels increased TAZ/TEAD-dependent transcription and primed cells for enhanced TAZ activity upon a second stimulus (i.e. sphingosine 1-phosphate) that induced nuclear TAZ translocation. In conclusion, our results uncover an important aspect of the cross-talk between TGFβ and Hippo signaling, showing that TGFβ induces TAZ via a Smad3-independent, p38- and MRTF-mediated and yet MRTF translocation-independent mechanism.

Tead Transcription Factors Mediate the Function of Taz in Cell Growth and Epithelial-Mesenchymal Transition

Taz Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and is Inhibited by the Hippo Pathway

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Teads Mediate Nuclear Retention of Taz to Promote Oncogenic Transformation

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Hippo Transducer Taz Promotes Epithelial Mesenchymal Transition and Supports Pancreatic Cancer Progression

TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

The Tumor Suppressor NF2 Modulates TEAD4 Stability and Activity in Hippo Signaling Via Direct Interaction

The Hippo Tumor Pathway Promotes Taz Degradation By Phosphorylating A Phosphodegron And Recruiting The Scf Beta-Trcp E3 Ligase

Regulation and Function of the TAZ Transcription Co-Activator.

TGF-β1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism

YAP1-TAZ/TEAD Transcriptional Networks Restrain Differentiation Downstream of Oncogenic Hedgehog-SMO Activity

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex

YAP1/TAZ-TEAD Transcriptional Networks Maintain Skin Homeostasis by Regulating Cell Proliferation and Limiting KLF4 Activity.

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation

The direct interaction with transcriptional factor TEAD4 implied a straightforward regulation mechanism of tumor suppressor NF2

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway

The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.